Pharmafile Logo
Pharmafocus logo
Advanced Search

breast cancer

Showing 12 posts of 177 posts found.

Roche submits new version of Herceptin for US approval

July 7, 2010
Research and Development, Sales and Marketing Herceptin, Roche, breast cancer

Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …

News

Novelos abandons candidate in lung cancer

March 20, 2010
Research and Development NSCLC, breast cancer

 

News

European approval for ‘double strength’ Faslodex

March 19, 2010
Sales and Marketing AstraZeneca, Faslodex, breast cancer

AstraZeneca’s Faslodex has expanded its European licence after winning approval to treat women with hormone receptor-positive breast cancer in a …

News

Sanofi’s BSI-201 tipped for success in triple negative breast cancer

February 28, 2010
Sales and Marketing Cancer, PARP, Sanofi, breast cancer

 Sanofi-Aventis’s BSI-201 will garner sales of $1.7 billion in the triple negative breast cancer drug market in 2018, according to …

News

Sanofi’s breast cancer candidate tipped for future success

February 25, 2010
Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer

A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …

News

Nexavar shows promise in breast cancer

September 24, 2009
Sales and Marketing Cancer, Nexavar, breast cancer

 Bayer’s Nexavar has been shown to significantly extend progression-free survival in patients with advanced breast cancer in a new phase …

News

Avastin shows promise in advanced breast cancer

August 20, 2009
Research and Development, Sales and Marketing Roche, avastin, breast cancer

Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …

News

GSK hopeful of NICE approval for Tyverb

January 26, 2009
Sales and Marketing Cancer, GSK, breast cancer

NICE could be poised to reverse its rejection of GSK's breast cancer treatment Tyverb, the pharma company has said.NICE rejected …

News

BMS breast cancer drug rejected

November 27, 2008
Sales and Marketing BMS, Cancer, breast cancer

Bristol-Myers Squibb's breast cancer drug Ixempra has suffered a setback in the EU over safety concerns.The Committee for Medicinal Products …

News

GSK’s pricing deal for Tyverb fails to sway NICE

October 15, 2008
Sales and Marketing GSK, NICE, breast cancer

NICE has spurned GSK's risk-sharing proposal for its breast cancer treatment Tyverb, saying the drug is still too expensive to …

News

Tyverb gains first approval in US

March 14, 2007
Sales and Marketing breast cancer

GlaxoSmithKline's breast cancer drug, Tyverb, has been approved in the US and could help women who have failed to respond …

News

GSK to test Tycerb for head and neck cancer

March 7, 2007
Sales and Marketing breast cancer

GlaxoSmithKline is to trial its potential blockbuster Tycerb for a new indication in head and neck cancer.Tycerb was only submitted …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025